Trial intelligence / Profile preview

Effects of Inhaled Glucocorticoids on Postmenopausal Skeleton

NCT02357277Phase 4Withdrawn

Sponsor
Columbia University
Start
Mar 2015
Primary completion
Nov 2017
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of budesonide in asthma (3 arms), sponsored by Columbia University. Primary endpoint: Change in Osteocalcin at 4 weeks. Planned start Mar 2015; status: withdrawn.

02

Drugs

budesonide
03

Conditions

asthma

Beyond the preview

Go deeper on NCT02357277.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02357277.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call